國家衛生研究院 NHRI:Item 3990099045/16027
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 855069      線上人數 : 958
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/16027


    題名: An Overview of New Psychoactive Substances (NPS) Analysis and Trends in Taiwan, 2008-2022
    作者: Kang, KH;Chen, WT;Liao, YC;Chen, WJ
    貢獻者: Center for Neuropsychiatric Research
    摘要: Aim: Supervising drug abuse trend is very important and help government projected to take preventive measures in implementing early intervention. This research provided the recent prevalence of new psychoactive substances (NPS) in Taiwan. Methods: The Taiwan government has established a drug abuse supervising mechanism, which all certification analytical agencies or institutions reported the test results of seized specimens via the “Drug Abuse Test Report System” (UDARS) to the Food and Drug Administration (TFDA), Ministry of Health and Welfare. To get an insight to status of NPS abuse patterns and epidemic trends in Taiwan, we analyzed the data from the UDARS between 2008 and 2022. Results: During this time-period over 1,000,000 sample and 179 different NPS were identified in seized specimens. Furthermore, the majority NPS category of all samples during this time frame were shifting from phencyclidine-type substances in 2008 to synthetic cathinones in 2022. The stimulants were the most popular NPS in recent years. Greater than 50 different synthetic cathinones were confirmed in seized sample, with the most prevalent compound in 2022 being 4-methylmethcathinone (mephedrone, meow meow). Conclusions: Our results provided an evidence-based data analysis and trend of NPS in Taiwan. These data will be useful what we can do to response activities to avoid health problems by NPS in Taiwan.
    日期: 2024-07-01
    關聯: Drug and Alcohol Dependence. 2024 Jul 01;260(Suppl.):Meeting Abstract 110357.
    Link to: http://dx.doi.org/10.1016/j.drugalcdep.2023.110357
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0376-8716&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001280690400383
    顯示於類別:[其他] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI001280690400383.pdf242KbAdobe PDF23檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋